High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen.
Hung-Chin TsaiI-Tzu ChenHui-Min ChangSusan Shin-Jung LeeYao-Shen ChenPublished in: Infection and drug resistance (2022)
Our findings showed a high rate of doravirine cross-resistance in patients with NNRTI-based STR treatment failure. Doravirine should be used cautiously as a salvage regimen in patients who fail NNRTI treatment.